Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
Fully Valued Stocks on TSX
Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.
In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on TSX
Today’s data is for companies listed on the TSX Venture Exchange.
|Symbol||Name||Target Year||Close Price||Target Price Mean||Currency||Target Price # of Estimates|
|ATM||Atacama Pacific Gold Corp||2019||0.600000||0.5000||CAD||1|
|EPI||ESSA Pharma Inc||2018||4.400000||1.7785||CAD||1|
|PNE.R||Pine Cliff Energy Ltd||2018||0.920000||0.4539||CAD||13|
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
ATM:TSX Atacama Pacific Gold
Atacama Pacific Gold has 13 employees and is headquartered in Canada.
Atacama Pacific Gold Corp is a Canada based company involved in metals and minerals business sector. The company is engaged in the acquisition, exploration and development of gold properties in Chile.
EPI:TSX ESSA Pharma
ESSA Pharma has 15 employees and is headquartered in Canada.
ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.